Structure |
Chemical Name |
CAS |
MF |
![Milnacipran IMpurity](/CAS/20210111/GIF/810696-16-3.gif) |
Milnacipran IMpurity |
810696-16-3 |
C11H11NO |
![Terbutaline IMpurity 8](/CAS/20210111/GIF/28924-20-1.gif) |
Terbutaline IMpurity 8 |
28924-20-1 |
C26H30BrNO3 |
![Etoricoxib IMpurity](/CAS/20181212/GIF/1350206-14-2.gif) |
Etoricoxib IMpurity |
1350206-14-2 |
C18H16N2O2S |
![1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N- ((5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl) methyl)-N-methylmethanamine hydrochloride](/CAS/20180702/GIF/CB14033522.gif) |
1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N- ((5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl) methyl)-N-methylmethanamine hydrochloride |
|
C33H28ClF2N5O4S2 |
![Labetalol EP impurity D](/CAS/20211123/GIF/32780-65-7.gif) |
Labetalol EP impurity D |
32780-65-7 |
C9H13ClN2O3 |
![ethyl (4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b] pyridin-3-yl)pyrimidin-5-yl)(methyl)carbamate](/CAS/20180702/GIF/625115-53-9.gif) |
ethyl (4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b] pyridin-3-yl)pyrimidin-5-yl)(methyl)carbamate |
625115-53-9 |
C21H21FN8O2 |
![2-[(4-CHLORO-2-NITROPHENYL)AMINO]-BENZOIC ACID](/CAS/GIF/60091-87-4.gif) |
2-[(4-CHLORO-2-NITROPHENYL)AMINO]-BENZOIC ACID |
60091-87-4 |
C13H9ClN2O4 |
![Fulvestrant impurity I](/) |
Fulvestrant impurity I |
|
|
![Emtricitabine](/CAS/20210111/GIF/61548-81-0.gif) |
Emtricitabine |
61548-81-0 |
C11H22O3S |
![tert-butyl 4-(3-nitropyridin-4-yl)piperazine-1-carboxylate](/CAS/20180713/GIF/608142-93-4.gif) |
tert-butyl 4-(3-nitropyridin-4-yl)piperazine-1-carboxylate |
608142-93-4 |
C14H20N4O4 |
![4-BROMO-1-(TOLUENE-4-SULFONYL)-1,2,3,4-TETRAHYDROBENZO[B]AZEPIN-5-ONE](/CAS/GIF/29489-04-1.gif) |
4-BROMO-1-(TOLUENE-4-SULFONYL)-1,2,3,4-TETRAHYDROBENZO[B]AZEPIN-5-ONE |
29489-04-1 |
C17H16BrNO3S |
![FEXOFENADINE, METHYL ESTER](/StructureFile/ChemBookStructure9/GIF/CB1457294.gif) |
FEXOFENADINE, METHYL ESTER |
154825-96-4 |
C33H41NO4 |
![Bendamustine Related Impurity 21](/) |
Bendamustine Related Impurity 21 |
|
|
![Bendamustine Related Impurity 8](/) |
Bendamustine Related Impurity 8 |
|
|
![Bortezomib Impurity 33](/) |
Bortezomib Impurity 33 |
|
|
![Moxifloxacin Impurity 31](/) |
Moxifloxacin Impurity 31 |
|
|
![Pitavastatin Impurity 7](/) |
Pitavastatin Impurity 7 |
|
|
![Prednisolone Impurity A](/CAS/20200119/GIF/77017-17-5.gif) |
Prednisolone Impurity A |
77017-17-5 |
C21H26O5 |
![Tegafur Impurity BCB](/) |
Tegafur Impurity BCB |
|
|
![((2R,3R,4R)-3-(benzoyloxy)-4-chloro-4-Methyl-5-oxotetrahydrofuran-2-yl)Methyl benzoate](/CAS/20150408/GIF/1496551-65-5.gif) |
((2R,3R,4R)-3-(benzoyloxy)-4-chloro-4-Methyl-5-oxotetrahydrofuran-2-yl)Methyl benzoate |
1496551-65-5 |
C20H17ClO6 |
![2-(4-fluorophenyl)-5-(2-Methylbenzyl)thiophene](/CAS/20150408/GIF/CB12715972.gif) |
2-(4-fluorophenyl)-5-(2-Methylbenzyl)thiophene |
2005454-69-1 |
C18H15FS |
![AcetaMide, N-[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]-](/CAS/20150408/GIF/1429334-00-8.gif) |
AcetaMide, N-[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]- |
1429334-00-8 |
C16H19N3O5 |
![PSI 7411](/CAS/20180808/GIF/1015073-43-4.gif) |
PSI 7411 |
1015073-43-4 |
C10H14FN2O8P |
![5-[[4-(Hydroxymethyl)phenoxy]methyl]-3-(1-methylethyl)-2-oxazolidinone](/CAS/20150408/GIF/1071765-44-0.gif) |
5-[[4-(Hydroxymethyl)phenoxy]methyl]-3-(1-methylethyl)-2-oxazolidinone |
1071765-44-0 |
C14H19NO4 |
![(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol 2,3,4,6-tetrakis(2,2-dimethylpropanoate)](/CAS/20180906/GIF/1283129-18-9.gif) |
(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol 2,3,4,6-tetrakis(2,2-dimethylpropanoate) |
1283129-18-9 |
C44H57FO9S |
![[1,4'-Bipiperidine]-1'-carboxylic acid](/CAS/20150408/GIF/1026078-50-1.gif) |
[1,4'-Bipiperidine]-1'-carboxylic acid |
1026078-50-1 |
C11H20N2O2 |
![4-[[3-(1-Methylethyl)-2-oxo-5-oxazolidinyl]methoxy]benzaldehyde](/CAS/20150408/GIF/1173203-26-3.gif) |
4-[[3-(1-Methylethyl)-2-oxo-5-oxazolidinyl]methoxy]benzaldehyde |
1173203-26-3 |
C14H17NO4 |
![Ibrutinib Impurity 9](/CAS/20180527/GIF/2068022-09-1.gif) |
Ibrutinib Impurity 9 |
2068022-09-1 |
C25H21D5N6O4 |
![4-CHLORO-3-HYDROXY BUTYRONITRILE](/CAS/GIF/105-33-9.gif) |
4-CHLORO-3-HYDROXY BUTYRONITRILE |
105-33-9 |
C4H6ClNO |
![(Z)-2-propylhept-2-enal](/CAS/20180529/GIF/95667-14-4.gif) |
(Z)-2-propylhept-2-enal |
95667-14-4 |
C10H18O |
![(R)-3-AMINO-4-(2,4-DIFLUOROPHENYL)-BUTYRIC ACID-HCL](/CAS/20180529/GIF/1335470-16-0.gif) |
(R)-3-AMINO-4-(2,4-DIFLUOROPHENYL)-BUTYRIC ACID-HCL |
1335470-16-0 |
C10H11F2NO2 |
![(R)-2-((3-methyl-6-(3-((1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile](/CAS/20180629/GIF/CB13955179.gif) |
(R)-2-((3-methyl-6-(3-((1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile |
|
C23H25N7O4 |
![(R)-2-((3-methyl-6-(3-((1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile](/CAS/20180629/GIF/CB13955179.gif) |
(R)-2-((3-methyl-6-(3-((1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile |
|
C23H25N7O4 |
![4,4'-dichloro-3,3'-bis(4-ethoxybenzyl)-1,1'-biphenyl](/CAS/20180629/GIF/CB13955982.gif) |
4,4'-dichloro-3,3'-bis(4-ethoxybenzyl)-1,1'-biphenyl |
2176485-21-3 |
C30H28Cl2O2 |
![N-(2,6-dimethylphenyl)-2-((2,6-dimethylphenyl)amino)acetamide](/CAS/20180629/GIF/294852-91-8.gif) |
N-(2,6-dimethylphenyl)-2-((2,6-dimethylphenyl)amino)acetamide |
294852-91-8 |
C18H22N2O |
![N6-propyl-3a,4,5,6,7,7a-hexahydrobenzo[d]thiazole-2,6-diamine](/CAS/20180629/GIF/1052691-22-1.gif) |
N6-propyl-3a,4,5,6,7,7a-hexahydrobenzo[d]thiazole-2,6-diamine |
1052691-22-1 |
C10H19N3S |
![3-pentylisoindolin-1-one](/CAS/20180629/GIF/691863-84-0.gif) |
3-pentylisoindolin-1-one |
691863-84-0 |
C13H17NO |
![(1R,3R)-2-acetyl-1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro- 1H-pyrido[3,4-b]indole-3-carboxylate](/CAS/20180629/GIF/1598416-05-7.gif) |
(1R,3R)-2-acetyl-1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro- 1H-pyrido[3,4-b]indole-3-carboxylate |
1598416-05-7 |
C22H20N2O5 |
![Rivaroxaban Impurity 61](/CAS/20200515/GIF/1643354-27-1.gif) |
Rivaroxaban Impurity 61 |
1643354-27-1 |
C32H30N4O8 |
![Rivaroxaban Impurity 74](/) |
Rivaroxaban Impurity 74 |
|
|
![Sitafloxacin Impurity 6](/) |
Sitafloxacin Impurity 6 |
|
|
![Ticagrelor Related Compound 75](/) |
Ticagrelor Related Compound 75 |
|
|
![Ticagrelor Related Compound 93](/CAS/20210111/GIF/2207528-55-8.gif) |
Ticagrelor Related Compound 93 |
2207528-55-8 |
C23H28F2N6O4S |
![Vonoprazan Impurity 24](/CAS/20200515/GIF/1807642-41-6.gif) |
Vonoprazan Impurity 24 |
1807642-41-6 |
C16H14FN3O2S |
![Vonoprazan Impurity 35](/) |
Vonoprazan Impurity 35 |
|
|
![Adefovir Impurity 2](/) |
Adefovir Impurity 2 |
|
|
![Avibactam Impurity R](/) |
Avibactam Impurity R |
|
|
![Blonanserin Impurity L](/) |
Blonanserin Impurity L |
|
|
![Cefazolin USP Impurity E](/) |
Cefazolin USP Impurity E |
|
|
![Exemestane Impurity 5](/) |
Exemestane Impurity 5 |
|
|
![Medetomidine Impurity 28](/CAS/20200515/GIF/2240179-64-8.gif) |
Medetomidine Impurity 28 |
2240179-64-8 |
C23H28N2 |
![Peramivir Impurity 4](/CAS/20200515/GIF/229615-12-7.gif) |
Peramivir Impurity 4 |
229615-12-7 |
C15H28N4O4 |
![Peramivir Impurity 9](/) |
Peramivir Impurity 9 |
|
|
![PidotimodImpurity T](/) |
PidotimodImpurity T |
|
|
![EMpagliflozin iMpurity 9](/) |
EMpagliflozin iMpurity 9 |
|
|
![EMpagliflozin iMpurity 14](/CAS/20211123/GIF/2137418-13-2.gif) |
EMpagliflozin iMpurity 14 |
2137418-13-2 |
C23H27ClO8 |
![570403-04-2](/CAS/20200515/GIF/570403-04-2.gif) |
570403-04-2 |
570403-04-2 |
C23H24Cl3N5OS2 |
![ibrutinib iMpurity A](/) |
ibrutinib iMpurity A |
|
|
![Sunitinib iMpurity E](/) |
Sunitinib iMpurity E |
|
|
![Rosuvastatin EP impurity H](/CAS/20210111/GIF/1335110-44-5.gif) |
Rosuvastatin EP impurity H |
1335110-44-5 |
C22H28FN3O6S |
![Saxagliptin Impurity 4 (Deoxy Saxagliptin)](/) |
Saxagliptin Impurity 4 (Deoxy Saxagliptin) |
|
|
![Betamethasone EP Impurity D](/CAS/20180629/GIF/52619-05-3.gif) |
Betamethasone EP Impurity D |
52619-05-3 |
C25H33FO7 |
![Dihydropenicillin F Potassium Salt](/CAS/20211123/GIF/31447-86-6.gif) |
Dihydropenicillin F Potassium Salt |
31447-86-6 |
C14H23KN2O4S |
![Etoricoxib Impurity 7](/CAS/20200611/GIF/646459-39-4.gif) |
Etoricoxib Impurity 7 |
646459-39-4 |
C20H21N3O2S |
![Mupirocin Impurity D](/CAS/20180629/GIF/CB12741867.gif) |
Mupirocin Impurity D |
|
C26H44O9 |
![Pazopanib Related Compound 2](/CAS/20210111/GIF/1226500-02-2.gif) |
Pazopanib Related Compound 2 |
1226500-02-2 |
C26H23ClN10 |
![Phenylephrine EP Impurity D](/CAS/20180629/GIF/1367567-95-0.gif) |
Phenylephrine EP Impurity D |
1367567-95-0 |
C16H19NO2 |
![Verapamil Impurity O](/CAS/20180629/GIF/959011-16-6.gif) |
Verapamil Impurity O |
959011-16-6 |
C27H38N2O4 |
![1,1′-[(1-Methylethyl)imino]bis[3-[4-(2-methoxyethyl)phenoxy]-2-propanol hydrochloride](/CAS/20211123/GIF/1486464-40-7.gif) |
1,1′-[(1-Methylethyl)imino]bis[3-[4-(2-methoxyethyl)phenoxy]-2-propanol hydrochloride |
1486464-40-7 |
C27H42ClNO6 |
![4'-FLUOROCYCLOPROPANECARBOXANILIDE](/CAS/20180629/GIF/2354-89-4.gif) |
4'-FLUOROCYCLOPROPANECARBOXANILIDE |
2354-89-4 |
C10H10FNO |
![methyl(E)-4-(methylamino)but-2-enoate](/CAS/20180629/GIF/915788-22-6.gif) |
methyl(E)-4-(methylamino)but-2-enoate |
915788-22-6 |
C6H11NO2 |
![methyl(E)-4-(methylamino)but-2-enoate](/CAS/20180629/GIF/915788-22-6.gif) |
methyl(E)-4-(methylamino)but-2-enoate |
915788-22-6 |
C6H11NO2 |
![Levomilnacipran impurity](/) |
Levomilnacipran impurity |
|
|
![Sofosbuvir IMpurity 4](/) |
Sofosbuvir IMpurity 4 |
|
|
![1,3-bis(4-isobutylphenyl)butan-1-one](/CAS/20180702/GIF/CB13146797.gif) |
1,3-bis(4-isobutylphenyl)butan-1-one |
|
C24H32O |
![6-isobutyl-3-methyl-2,3-dihydro-1H-inden-1-one](/CAS/20180702/GIF/1340024-54-5.gif) |
6-isobutyl-3-methyl-2,3-dihydro-1H-inden-1-one |
1340024-54-5 |
C14H18O |
![Edoxaban impurity 1](/CAS/20180906/GIF/41374-72-5.gif) |
Edoxaban impurity 1 |
41374-72-5 |
C9H10N2O3 |
![Canagliflozin Impurity 18](/) |
Canagliflozin Impurity 18 |
|
|
![Canagliflozin Impurity 23](/) |
Canagliflozin Impurity 23 |
|
|
![Carfilzomib Impurity 4](/) |
Carfilzomib Impurity 4 |
|
|
![Lenvatinib Impurity 2](/CAS/20200611/GIF/2380197-90-8.gif) |
Lenvatinib Impurity 2 |
2380197-90-8 |
C28H22ClN5O5 |
![FeBuxostat Impurity 33](/CAS/20180808/GIF/100118-38-5.gif) |
FeBuxostat Impurity 33 |
100118-38-5 |
C12H14O5 |
![(S)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)](/CAS/20210111/GIF/1642630-12-3.gif) |
(S)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl) |
1642630-12-3 |
C22H22N6O |
![Latamoxef Impurity 1](/CAS/20210111/GIF/75007-70-4.gif) |
Latamoxef Impurity 1 |
75007-70-4 |
C19H20N6O7S |
![Amlodipine iMpurity K](/CAS/20180527/GIF/1809326-44-0.gif) |
Amlodipine iMpurity K |
1809326-44-0 |
C18H21ClN2O5 |
![Cabozantinib impurity 4](/CAS/20210111/GIF/95932-39-1.gif) |
Cabozantinib impurity 4 |
95932-39-1 |
C11H15NO3 |
![Rosuvastatin EP Impurity C](/CAS/20211123/GIF/1620823-61-1.gif) |
Rosuvastatin EP Impurity C |
1620823-61-1 |
C22H27FN3NaO6S |
![6,7-bis(2-methoxyethoxy)-N-phenylquinazolin-4-amine](/CAS/20180527/GIF/1145671-52-8.gif) |
6,7-bis(2-methoxyethoxy)-N-phenylquinazolin-4-amine |
1145671-52-8 |
C20H23N3O4 |
![(3R,4R,5S)-ethyl 4-acetamido-5-amino-3-isopropoxycyclohex-1-enecarboxylate](/CAS/20180527/GIF/1052063-36-1.gif) |
(3R,4R,5S)-ethyl 4-acetamido-5-amino-3-isopropoxycyclohex-1-enecarboxylate |
1052063-36-1 |
C14H24N2O4 |
![4-(N-(tert-butyl)acetamido)-5-(diallylamino)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate](/CAS/20180527/GIF/941296-96-4.gif) |
4-(N-(tert-butyl)acetamido)-5-(diallylamino)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate |
941296-96-4 |
C16H28N2O4 |
![(2R,5S)-5-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylic acid](/CAS/20180629/GIF/CB13159054.gif) |
(2R,5S)-5-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylic acid |
|
C8H8FN3O4S |
![Amlodipine Impurity 10](/CAS/20180629/GIF/CB13159160.gif) |
Amlodipine Impurity 10 |
2170104-51-3 |
C26H31ClN2O8S |
![Apixaban Impurity 15](/CAS/20200611/GIF/1466571-07-2.gif) |
Apixaban Impurity 15 |
1466571-07-2 |
C21H20N4O4 |
![Clopidogrel Impurity 8](/CAS/20180629/GIF/CB13159236.gif) |
Clopidogrel Impurity 8 |
|
C15H14ClNO2S |
![Acyclovir Impurity I: 7,9'-[Ethylene-bis(oxymethylene)] Bis (2-amino-1-9-dihydro-6H-purin-6-one)](/CAS/20200515/GIF/1797832-75-7.gif) |
Acyclovir Impurity I: 7,9'-[Ethylene-bis(oxymethylene)] Bis (2-amino-1-9-dihydro-6H-purin-6-one) |
1797832-75-7 |
C14H16N10O4 |
![Nilotinib genotoxic impurity 3](/CAS/20200611/GIF/915711-42-1.gif) |
Nilotinib genotoxic impurity 3 |
915711-42-1 |
C19H17F3N4O |
![Dapagliflozin Open Ring](/CAS/20200611/GIF/2100872-88-4.gif) |
Dapagliflozin Open Ring |
2100872-88-4 |
C21H27ClO7 |
![Rortezide impurity](/) |
Rortezide impurity |
|
|
![Aprepitant Impurity 2](/) |
Aprepitant Impurity 2 |
|
|
![Cabozantinib Impurity A](/) |
Cabozantinib Impurity A |
|
|